Argus
•
Mar 11, 2026
MYGN: What does Argus have to say about MYGN?
Summary
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Biogen Inc.
Sep 03, 2026
•
BIIB
Analyst Report: Illumina Inc
Sep 03, 2026
•
ILMN
Analyst Report: Qiagen N.V.
Sep 03, 2026
•
QGEN
Market Digest: ILMN, SLF, PANW, AXON
Sep 03, 2026
•
ILMN, AXON, SLF, PANW
Analyst Report: Alnylam Pharmaceuticals, Inc.
Sep 02, 2026
•
ALNY
